UA28031C2 - Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов - Google Patents

Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов

Info

Publication number
UA28031C2
UA28031C2 UA96083232A UA96083232A UA28031C2 UA 28031 C2 UA28031 C2 UA 28031C2 UA 96083232 A UA96083232 A UA 96083232A UA 96083232 A UA96083232 A UA 96083232A UA 28031 C2 UA28031 C2 UA 28031C2
Authority
UA
Ukraine
Prior art keywords
nitroimidasole
derivatives
microgranules
medicinal
gastrointestinal tract
Prior art date
Application number
UA96083232A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жерар Ледюк
Патріс Дебрежеа
Патрис Дебрежеа
Original Assignee
Лаборатуар Де Продюі Етік Етіфарм
Лаборатуар Де Продюи Етик Етифарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Лаборатуар Де Продюі Етік Етіфарм, Лаборатуар Де Продюи Етик Етифарм filed Critical Лаборатуар Де Продюі Етік Етіфарм
Publication of UA28031C2 publication Critical patent/UA28031C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UA96083232A 1994-01-14 1995-01-12 Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов UA28031C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
PCT/FR1995/000039 WO1995019168A1 (fr) 1994-01-14 1995-01-12 Microgranules de derives de 5-nitro imidazole

Publications (1)

Publication Number Publication Date
UA28031C2 true UA28031C2 (uk) 2000-10-16

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96083232A UA28031C2 (uk) 1994-01-14 1995-01-12 Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов

Country Status (19)

Country Link
JP (1) JPH09507499A (da)
KR (1) KR100320140B1 (da)
CN (1) CN1088357C (da)
AT (1) ATE187068T1 (da)
AU (1) AU705570B2 (da)
BR (1) BR9506507A (da)
CZ (1) CZ286080B6 (da)
DE (1) DE69513632T2 (da)
DK (1) DK0739201T3 (da)
ES (1) ES2139883T3 (da)
MA (1) MA23429A1 (da)
MX (1) MX9602772A (da)
NZ (1) NZ279238A (da)
OA (1) OA10583A (da)
PL (1) PL178424B1 (da)
PT (1) PT739201E (da)
RU (1) RU2152212C1 (da)
SK (1) SK282066B6 (da)
UA (1) UA28031C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU7909691A (en) * 1990-05-14 1991-12-10 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
BR9506507A (pt) 1997-09-09
DE69513632D1 (de) 2000-01-05
PL315530A1 (en) 1996-11-12
AU705570B2 (en) 1999-05-27
MX9602772A (es) 1997-05-31
CZ286080B6 (cs) 2000-01-12
SK91496A3 (en) 1996-12-04
CN1088357C (zh) 2002-07-31
CN1138826A (zh) 1996-12-25
NZ279238A (en) 1998-03-25
AU1580395A (en) 1995-08-01
PL178424B1 (pl) 2000-04-28
DK0739201T3 (da) 2000-05-01
MA23429A1 (fr) 1995-10-01
DE69513632T2 (de) 2000-04-06
ES2139883T3 (es) 2000-02-16
KR100320140B1 (ko) 2002-07-02
SK282066B6 (sk) 2001-10-08
ATE187068T1 (de) 1999-12-15
JPH09507499A (ja) 1997-07-29
CZ205596A3 (en) 1996-10-16
OA10583A (en) 2002-07-10
RU2152212C1 (ru) 2000-07-10
PT739201E (pt) 2000-05-31

Similar Documents

Publication Publication Date Title
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
MY129356A (en) Electrospun pharmaceutical compositions
TW355683B (en) Composition containing micronized nebivolol
WO2000030622A3 (de) Verwendung von dialkylfumaraten zur behandlung von host-versus-graft reaktionen und von autoimmunerkrankungen
MY124695A (en) Novel composition and use.
AU2002231691A1 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
AU2001295850A1 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
CA2294921A1 (en) Levobupivacaine and its use
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
UA28031C2 (uk) Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов
NZ501832A (en) Angiotensin-peptide carrier conjugates for treating diseases associated with the renin-angiotensin system
HUP0200529A3 (en) Optically pure camptothecin analogues, pharmaceutical compositions containing them and their use
WO2002041841A3 (en) Compositions for adhesion prevention
EP1221945A4 (en) METHOD AND PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS FOR THE ADMINISTRATION OF ADENOSINE
BG104692A (en) Extended release tiagabine formulation
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
AU1399100A (en) Therapeutic treatment with immunogenic drugs
PL314933A1 (en) Prophylatic and therapeutic agent for mouth care, in particular for preventing paradontium diseases